Bank of Montreal
MRKR icon

Bank of Montreal’s Marker Therapeutics MRKR Stock Holding History

Bank of Montreal’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,514
Closed -$33K – 4464
2021
Q1 		$33K Buy
1,514
+1,030
+213% +$23.6K ﹤0.01% 3872
2020
Q4 		$9K Buy
484
+347
+253% +$5.39K ﹤0.01% 4678
2020
Q3 		$2K Sell
137
-191
-58% -$3.48K ﹤0.01% 4635
2020
Q2 		$7K Buy
+328
New +$7.17K ﹤0.01% 4332
2020
Q1 		– Sell
-2,625
Closed -$76K – 4473
2019
Q4 		$76K Sell
2,625
-2,041
-44% -$74.3K ﹤0.01% 3623
2019
Q3 		$238K Buy
4,666
+4,440
+1,965% +$262K ﹤0.01% 2805
2019
Q2 		$18K Buy
+226
New +$13.4K ﹤0.01% 4241

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's MRKR Position: Q2 2021 in Review

Bank of Montreal sold out of Marker Therapeutics (MRKR) in Q2 2021, closing a stake of 1,514 shares — an estimated $33K sold.

Bank of Montreal first reported a position in MRKR in Q2 2019 and held it in 7 quarters. The position peaked at $238K in Q3 2019. 74 funds tracked by Wall St. Rank hold MRKR as of Q2 2021.

  • Bank of Montreal reported no remaining Marker Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,514 Marker Therapeutics shares in Q2 2021, an estimated $33K.
  • Bank of Montreal first reported a position in Marker Therapeutics in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's Marker Therapeutics position peaked at $238K in Q3 2019.
  • 74 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.